These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19142430)

  • 1. Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District.
    Lannoy LH; Cortez-Escalante JJ; Evangelista Mdo S; Romero GA
    Rev Soc Bras Med Trop; 2008; 41(6):549-55. PubMed ID: 19142430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Wilcosky TC; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1997 Jan; 126(2):123-32. PubMed ID: 9005746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis among HIV-1-infected subjects in a tertiary out-patient service in São Paulo city, Brazil.
    Casseb J; Fonseca LA; Medeiros LA; Gonsalez CR; Lagonegro ER; Veiga AP; da Silva DC; Mendonça M; Duarte AJ
    Rev Inst Med Trop Sao Paulo; 2012; 54(5):257-9. PubMed ID: 22983288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?
    Grant AD; Bansi L; Ainsworth J; Anderson J; Delpech V; Easterbrook P; Fisher M; Gazzard B; Gilson R; Gompels M; Hill T; Johnson M; Leen C; Orkin C; Phillips AN; Porter K; Post F; Walsh J; Sabin CA;
    AIDS; 2009 Nov; 23(18):2507-15. PubMed ID: 19770622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
    JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
    Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
    Lawn SD; Badri M; Wood R
    AIDS; 2005 Dec; 19(18):2109-16. PubMed ID: 16284460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
    Kassa A; Teka A; Shewaamare A; Jerene D
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated course of human immunodeficiency virus infection after tuberculosis.
    Whalen C; Horsburgh CR; Hom D; Lahart C; Simberkoff M; Ellner J
    Am J Respir Crit Care Med; 1995 Jan; 151(1):129-35. PubMed ID: 7812542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
    Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
    AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
    Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
    Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.
    Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J
    AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy.
    Girardi E; Antonucci G; Vanacore P; Palmieri F; Matteelli A; Iemoli E; Carradori S; Salassa B; Pasticci MB; Raviglione MC; Ippolito G;
    Eur Respir J; 2004 Jul; 24(1):11-7. PubMed ID: 15293599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.
    Mu W; Zhao Y; Sun X; Ma Y; Yu L; Liu X; Zhao D; Dou Z; Fang H; Zhang F
    AIDS Care; 2014; 26(9):1127-35. PubMed ID: 24512621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.